These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 186481)

  • 41. Characterization of dexamethasone binding in normal and uremic human serum.
    Cummings DM; Larijani GE; Conner DP; Ferguson RK; Rocci ML
    DICP; 1990 Mar; 24(3):229-31. PubMed ID: 2316228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A possible role of the kidney in activating a renin preinhibitor.
    Baggio B; Favaro S; Antonello A; Cannella G; Todesco S; Borsatti A
    Res Exp Med (Berl); 1975 Dec; 166(3):201-7. PubMed ID: 1215665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No evidence of active renin-inhibitors in plasma. The kinetics of the reaction between renin and substrate in non-pre-treated plasma.
    Poulsen K
    Scand J Clin Lab Invest; 1971 Feb; 27(1):37-46. PubMed ID: 4322399
    [No Abstract]   [Full Text] [Related]  

  • 44. [On changes in serum lipid fractions in young hypertensive patients].
    VOLKOVA VV
    Ter Arkh; 1961 Jul; 33():50-3. PubMed ID: 13782008
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of calcium and serum albumin on clearing of lipemic dog plasma in vitro.
    SEIFTER J; BAEDER DH
    Proc Soc Exp Biol Med; 1955 Aug; 89(4):511-4. PubMed ID: 13254811
    [No Abstract]   [Full Text] [Related]  

  • 46. The lipids of fish. II. The acetone-soluble lipids of the flesh of the haddock.
    LOVERN JA; OLLEY J
    Biochem J; 1953 Apr; 54(1):128-37. PubMed ID: 13058843
    [No Abstract]   [Full Text] [Related]  

  • 47. The lipids of fish. III. The acetone-insoluble fraction of an acetone extract of the flesh of the haddock.
    OLLEY J; LOVERN JA
    Biochem J; 1953 Jul; 54(4):559-69. PubMed ID: 13058951
    [No Abstract]   [Full Text] [Related]  

  • 48. Properties of clearing factor obtained from rat heart acetone powder.
    KORN ED
    Science; 1954 Sep; 120(3114):399-400. PubMed ID: 13186871
    [No Abstract]   [Full Text] [Related]  

  • 49. Association of an inhibitor with deficiency of plasma-clearing activity.
    KOPPEL JL; NOVAK LV; OLWIN JH
    J Appl Physiol; 1961 Jan; 16():115-8. PubMed ID: 13753084
    [No Abstract]   [Full Text] [Related]  

  • 50. On the so-called "Acetone-soluble Phosphatides.".
    Maclean H
    Biochem J; 1914 Oct; 8(5):453-9. PubMed ID: 16742332
    [No Abstract]   [Full Text] [Related]  

  • 51. PLASMA LIPIDS IN ESSENTIAL HYPERTENSION.
    Page IH; Kirk E; Van Slyke DD
    J Clin Invest; 1936 Jan; 15(1):109-13. PubMed ID: 16694370
    [No Abstract]   [Full Text] [Related]  

  • 52. The renin/angiotensin system.
    Lee MR
    Br J Clin Pharmacol; 1981 Nov; 12(5):605-12. PubMed ID: 6174135
    [No Abstract]   [Full Text] [Related]  

  • 53. Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.
    Brooks CS; Talwalker RT; Kotchen TA
    J Clin Endocrinol Metab; 1977 Feb; 44(2):322-9. PubMed ID: 838842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of renin inhibitors in normal and uremic plasma.
    Kotchen TA; Talwalkar RT; Kaul K
    J Lab Clin Med; 1985 Mar; 105(3):286-93. PubMed ID: 3882863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of renin reactivity by lipids extracted from normal, hypertensive, and uremic plasma.
    Kotchen TA; Talwalker RT; Miller MC; Welch WJ
    J Clin Endocrinol Metab; 1976 Nov; 43(5):971-81. PubMed ID: 186481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
    Kotchen TA; Talwalkar RT; Kotchen JM; Miller MC; Welch WJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):17-27. PubMed ID: 1132076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence against acetone-soluble renin inhibitors in normal human plasma.
    Druilhet RE; Overturf ML; Hinshaw RA; Kirkendall WM
    Hypertension; 1979; 1(2):98-105. PubMed ID: 399942
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.